Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lorazepam modulation of alpha and gamma oscillations during working memory
NL-OMON35861Active, not recruiting
- Sponsor
- Radboud University
- Start
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of lorazepam (3 arms), sponsored by Radboud University. Primary endpoint: Alpha and gamma oscillatory activity during working memory task. Started Nov 2011; status: active, not recruiting.
02
Drugs
lorazepam
Beyond the preview
Go deeper on NL-OMON35861.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON35861.